GenePath Diagnostics - About the company
GenePath Diagnostics is a seed company based in Pune (India), founded in 2008 by Nickhil Jakatdar, Nikhil Phadke and Nikhil Phadke. It operates as a Provider of diagnostic solutions for infectious diseases, cancers and genetic disorders. GenePath Diagnostics has raised $1.85M in funding from Snow Leopard Ventures and Saama Capital, with a current valuation of ₹*****. The company has 511 active competitors, including 87 funded and 69 that have exited. Its top competitors include companies like Roche, Neogen and Qiagen.
Company Details
Provider of diagnostic solutions for infectious diseases, cancers, and genetic disorders. The product portfolio includes DNA and RNA-based tests for infectious diseases, oncology, endocrinology, transplantation typing, hematology, pharmacogenetics, and pre-natal and pre-implantation genetic testing. The company is also involved in the detection of HPV, COVID-19 infection among others.
- Website
- www.genepathdx.com/
- Social
- Email ID
- *****@genepathdx.com
- Phone Number
- +91 **********
- Registered Address
- 1260 B JANGLI MAHARAJ ROAD SHIVAJINAGAR, PUNE, Maharashtra, India, 411004
Legal entities associated with GenePath Diagnostics
GenePath Diagnostics is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
I-SHARE FOUNDATION CIN: U85320PN2018NPL174246 , India, Active | Jan 10, 2018 | $84.7K (As on Mar 31, 2025) | - | |
GENEPATH DIAGNOSTICS INDIA PRIVATE LIMITED CIN: U74999PN2019PTC181759 , India, Active | Jan 29, 2019 | $820K (As on Mar 31, 2025) | 28 (As on Apr 30, 2025) | |
Genepath Diagnostics Inc CIN: 7251369 , United States, Active | Jan 24, 2019 | - | - | - |
CAUSEWAY HEALTHCARE PRIVATE LIMITED CIN: U73100PN2008PTC131542 , India, Active | Mar 04, 2008 | $820 (As on Mar 31, 2025) | 18 (As on Mar 31, 2019) |
Sign up to download GenePath Diagnostics' company profile
GenePath Diagnostics's funding and investors
GenePath Diagnostics has raised a total funding of $1.85M over 6 rounds. Its first funding round was on Mar 29, 2013. Its latest funding round was a Grant (prize money) round on Nov 23, 2020 for $*****. 1 investor participated in its latest round. GenePath Diagnostics has 6 institutional investors and 20 angel investors.
Here is the list of recent funding rounds of GenePath Diagnostics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 23, 2020 | 1723731 | Grant (prize money) | 3812066 | 2448197 | 2671887 | 7895419 |
2020 | 5521 | Seed | 2807 | 6056 | 7201 | 4234 |
May 11, 2017 | 8125373 | Seed | 3138109 | 2998105 | 4539434 |
Access funding benchmarks and valuations. Sign up today!View details of GenePath Diagnostics's funding rounds and investors
GenePath Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of GenePath Diagnostics are Nickhil Jakatdar, Nikhil Phadke and Nikhil Phadke. Nickhil Jakatdar is the CEO of GenePath Diagnostics.
Here are the details of GenePath Diagnostics' key team members:
- Nickhil Jakatdar: Co-Founder & CEO of GenePath Diagnostics and founder of 1 other company. They are also an angel investor in 2 startups and serve on the board of 1 company.
- Nikhil Phadke: Co-Founder of GenePath Diagnostics. They serve on the board of 1 company.Contact Info: 1 email address
- Nikhil Phadke: Founder Director and Chief Scientific Officer of GenePath Diagnostics.
GenePath Diagnostics' Board of Directors
GenePath Diagnostics's board has 2 active members. Nikhil Phadke is part of team and Firdaus Jal Dastoor is independent board member.Here is the list of GenePath Diagnostics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 18y 0m | |
cxuhdje | Team | - | Past | 8y 1m |
yy{gahx | Team | - | Past | 8y 1m |
Independent board member | - | Current | 10y 11m | |
u{lxzgc | Independent board member | - | Past | 4y 5m |
kfkbwtg | Independent board member | - | Past | 3y 3m |
vctrixk | Independent board member | - | Past | 3y 5m |
axnaogh | Independent board member | - | Past | 1y 5m |
View details of GenePath Diagnostics's Founder profiles and Board Members
GenePath Diagnostics' employee count trend
GenePath Diagnostics has 54 employees as of Apr 26. Here is GenePath Diagnostics's employee count trend over the years:
Uncover GenePath Diagnostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GenePath Diagnostics's Competitors and alternates
Top competitors of GenePath Diagnostics include Roche, Neogen and Qiagen. Here is the list of Top 10 competitors of GenePath Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 69/100 | |
2nd | Neogen 1982, Lansing (United States), Acquired | Solutions for food and animal safety, diagnostics, and genomics | $700K | 67/100 | |
3rd | Qiagen 1984, Venlo (Netherlands), Acquired | Provider of products and reagents for molecular diagnostic assays | - | 65/100 | |
4th | Paragon Genomics 2015, San Francisco (United States), Series A | Provider of technologies and solutions genomic research and precision medicine | $8M | 64/100 | |
5th | Parse Biosciences 2018, Seattle (United States), Series C | Developer of RNA-sequencing solution-based transcriptome kit to analyze health data | $100M | 64/100 | |
6th |  NVision Imaging Technologies 2015, Ulm (Germany), Series A | Provider of medical imaging by quantum technologies | $35M | 62/100 | |
7th | JUMPCODE Genomics 2016, Carlsbad (United States), Series B | Provider of a technology for depleting unwanted nucleic acid | $38.7M | 59/100 | |
8th | LGC 1842, Teddington (United Kingdom), Acquired | Provider of analytical testing, reference materials, and diagnostic and therapeutic products | - | 59/100 | |
9th | Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy | $26.8M | 57/100 | ||
10th |  EKF 1990, Penarth (United Kingdom), Public | Develops point-of-care and laboratory blood analyzers | $179K | 57/100 | |
76th | GenePath Diagnostics 2008, Pune (India), Seed | Provider of diagnostic solutions for infectious diseases, cancers and genetic disorders | $1.85M | 42/100 |
_1580727887253.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GenePath Diagnostics's competitors? Click here to see the top ones
GenePath Diagnostics's Latest cap tables and shareholding
Founders own 30.16%, Funds (largest shareholder) own 35.88%, Angels own 3.08% and Other People own 2.16%. The net worth of GenePath Diagnostics's founders is INR 7.14Cr as of Feb 01, 2016.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 30.16% | 7.14Cr | 9976035 | 3319677 | 7189608 | 6861505 |
1940946 | 2531490 | 2608267 | 4517849 | 6906419 | 7161941 | |
Fund | 35.88% | 8.5Cr | 5978856 | 2088414 | 3119853 | 7886591 |
2562058 | 5079581 | 4633089 | 2677507 | 2037682 | 5847839 | |
Angel | 3.08% | 73.3L | 975 | 539 | 686 | 348 |
Other People | 2.16% | 51.2L | 39 | 44 | 37 | 13 |
Total | 71.28% | 16.9Cr | 9046160 | 1242160 | 5325188 | 2562694 |
To unlock detailed Cap Table of GenePath Diagnostics Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of GenePath Diagnostics's Shareholding
GenePath Diagnostics's Investments and acquisitions
GenePath Diagnostics has made no investments or acquisitions yet.
Reports related to GenePath Diagnostics
Here is the latest report on GenePath Diagnostics's sector:
News related to GenePath Diagnostics
•
‘GenePath’s testing kit found accurate in detecting Delta, Omicron variants’The Indian Express•Jan 24, 2022•GenePath Diagnostics
•
GenePath Diagnostics kit detects Delta, Omicron variantsTechiLive.in•Dec 18, 2021•GenePath Diagnostics
•
•
RT-PCR test kit of Pune firm gets nod for manufacture, sale in IndiaThe Hindu•Sep 04, 2020•GenePath Diagnostics
•
GenePath diagnostics opens Pune's first drive-up Covid-19 test centreIndiatimes•Aug 29, 2020•GenePath Diagnostics
•
Causeway Healthcare raises fresh funds from existing investorVCCircle•Jul 05, 2017•GenePath Diagnostics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about GenePath Diagnostics
Explore our recently published companies
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Funding Raised company
- Beacon Display - Sutton Coldfield based, 1976 founded, Unfunded company
- Lonsen Kiri Chemical Industries - Vadodara based, 2008 founded, Unfunded company
- Pltindustries - Delhi based, 1995 founded, Unfunded company
